Humana (NYSE:HUM) Rating Lowered to Market Perform at Leerink Partners

Leerink Partners cut shares of Humana (NYSE:HUM – Free Report) from an outperform rating to a market perform rating in a research note released on Wednesday morning, MarketBeat Ratings reports. Leerink Partners currently has $250.00 price objective on the insurance provider’s stock, down from their prior price objective of $400.00. Other equities analysts have also […]

Leave a Reply

Your email address will not be published.

Previous post Michael Skynner Sells 972 Shares of Bicycle Therapeutics plc (NASDAQ:BCYC) Stock
Next post Insider Selling: Block, Inc. (NYSE:SQ) CAO Sells $33,500.00 in Stock